Palantir stock is in focus for Canadian investors after a UBS upgrade to Buy following a pullback. Management’s guidance for 115% U.S. commercial growth points to strong AI revenue growth and rising commercial demand. With shares tracking below short-term averages and a premium valuation supported by improving margins, a re-rating case is building. We review price action, fundamentals, and what this means in Canada, plus key dates and levels to watch for PLTR. We also outline currency considerations when buying U.S.-listed names in CAD.

Why UBS Turned Bullish After the Pullback

Year to date, shares are down 18.27% and sit below the 50-day average, while ADX at 28.57 indicates a strong trend that can swing fast. UBS upgrade to Buy cites attractive entry after the pullback and better customer momentum. That aligns with rising commercial demand and pipeline commentary. See coverage for context: source.

Management reiterated guidance calling for 115% growth in U.S. commercial, a clear sign of accelerating AI revenue growth across AIP use cases. High gross margins and improving operating leverage support the case for a re-rating if execution holds. For details on the guidance backdrop, see this report: source.

What the Numbers Say Now

RSI at 43 shows neutral momentum, while the MACD histogram turned positive. Price hovers near the Bollinger middle band around 137.08, with upper and lower bands at 151.07 and 123.09. A decisive close above the middle band could open room toward the upper band. Volume is near average, suggesting no blow-off or capitulation as traders reassess the path for Palantir stock.

Palantir stock trades at a high P/E near 218, with price to sales above 69, yet fundamentals are improving. Gross margin is 82.37%, net margin 36.31%, and current ratio 7.11, with low leverage. Free cash flow yield is about 0.68%. Analysts show 17 Buy, 15 Hold, 5 Sell, implying a mixed but improving stance as execution and commercial demand trends hold.

Implications for Canadian Investors

Canadians buy a U.S.-listed name, so returns will include CAD-USD moves. Consider staged buys to average FX, or hedged exposure if currency volatility is a concern. With no dividend, there is no withholding tax drag in registered accounts like RRSPs or TFSAs. Keep position sizes in check given valuation, and align entries with technical confirmation on Palantir stock.

Earnings are scheduled for May 4, 2026. Watch U.S. commercial bookings, customer adds, and margin progress. On the chart, a close back above the Bollinger midline near 137 and sustained strength toward the 50-day average near 162 would support the UBS case. Any slowdown in AI revenue growth could pressure the premium attached to Palantir stock.

Final Thoughts

UBS turning positive after the recent slide, paired with management’s 115% U.S. commercial growth outlook, strengthens the bull case for Palantir stock. The setup features improving margins, solid cash metrics, and neutral-to-improving momentum indicators. Risks remain, notably a premium multiple and sensitivity to any wobble in commercial traction. For Canadian investors, plan entries in stages, mind currency exposure, and track execution closely. Into the next earnings print, focus on U.S. commercial bookings, net customer adds, and operating leverage. A confirmed move above key technical levels could signal the next leg, while any miss on growth may cap near-term upside.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.